Search research articles
Contact Us
Filters
Showing results (571-580 of 636) with videos related to
Page
of 64
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 3, 2009
Plasma triglycerides and LDL cholesterol are related in a parabolic fashion in the general population and patients with Type 2 diabetes mellitus: long-term follow-up results from the Hoorn study
M C G J Brouwers, J M Dekker, M M J van Greevenbroek, et al.
Lancet (London, England)
|
October 14, 2014
Exercises to improve function of the rheumatoid hand (SARAH): a randomised controlled trial
Sarah E Lamb, Esther M Williamson, Peter J Heine, et al.
Dementia and Geriatric Cognitive Disorders
|
October 9, 2008
Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: the Hoorn study
Esther van den Berg, Jacqueline M Dekker, Giel Nijpels, et al.
Metabolism: Clinical and Experimental
|
November 21, 2012
Islet-cell dysfunction induced by glucocorticoid treatment: potential role for altered sympathovagal balance?
Daniël H van Raalte, Kelly A A Kwa, Renate E van Genugten, et al.
Journal of Internal Medicine
|
October 16, 2004
Prevalence of macrovascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn Screening Study
A M W Spijkerman, R M A Henry, J M Dekker, et al.
The Netherlands Journal of Medicine
|
March 20, 2008
Deteriorating glucose tolerance status is associated with left ventricular dysfunction--the Hoorn Study
R M A Henry, W J Paulus, O Kamp, et al.
Diabetes/Metabolism Research and Reviews
|
September 22, 2009
Blood pressure levels in pre-diabetic stages are associated with worse cognitive functioning in patients with type 2 diabetes
Esther van den Berg, Jacqueline M Dekker, Giel Nijpels, et al.
Diabetes Care
|
February 7, 2009
One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial
Mathijs C Bunck, Michaela Diamant, Anja Cornér, et al.
Diabetologia
|
May 22, 2010
Diabetes, prediabetes and cancer mortality
X H Zhou, Q Qiao, B Zethelius, et al.
Diabetes
|
January 30, 2004
Mitochondrial diabetes: molecular mechanisms and clinical presentation
J Antonie Maassen, Leen M 'T Hart, Einar Van Essen, et al.
Page
of 64
Search research articles
Search
Showing results (571-580 of 636) with videos related to
Sort By:
Page
of 64
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 3, 2009
Plasma triglycerides and LDL cholesterol are related in a parabolic fashion in the general population and patients with Type 2 diabetes mellitus: long-term follow-up results from the Hoorn study
M C G J Brouwers, J M Dekker, M M J van Greevenbroek, et al.
Lancet (London, England)
|
October 14, 2014
Exercises to improve function of the rheumatoid hand (SARAH): a randomised controlled trial
Sarah E Lamb, Esther M Williamson, Peter J Heine, et al.
Dementia and Geriatric Cognitive Disorders
|
October 9, 2008
Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: the Hoorn study
Esther van den Berg, Jacqueline M Dekker, Giel Nijpels, et al.
Metabolism: Clinical and Experimental
|
November 21, 2012
Islet-cell dysfunction induced by glucocorticoid treatment: potential role for altered sympathovagal balance?
Daniël H van Raalte, Kelly A A Kwa, Renate E van Genugten, et al.
Journal of Internal Medicine
|
October 16, 2004
Prevalence of macrovascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn Screening Study
A M W Spijkerman, R M A Henry, J M Dekker, et al.
The Netherlands Journal of Medicine
|
March 20, 2008
Deteriorating glucose tolerance status is associated with left ventricular dysfunction--the Hoorn Study
R M A Henry, W J Paulus, O Kamp, et al.
Diabetes/Metabolism Research and Reviews
|
September 22, 2009
Blood pressure levels in pre-diabetic stages are associated with worse cognitive functioning in patients with type 2 diabetes
Esther van den Berg, Jacqueline M Dekker, Giel Nijpels, et al.
Diabetes Care
|
February 7, 2009
One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial
Mathijs C Bunck, Michaela Diamant, Anja Cornér, et al.
Diabetologia
|
May 22, 2010
Diabetes, prediabetes and cancer mortality
X H Zhou, Q Qiao, B Zethelius, et al.
Diabetes
|
January 30, 2004
Mitochondrial diabetes: molecular mechanisms and clinical presentation
J Antonie Maassen, Leen M 'T Hart, Einar Van Essen, et al.
Page
of 64